🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 53 of 200 · A–Z by INN

  1. desvenlafaxine fumarate

    DESVENLAFAXINE Teva Pharma GmbH

    ORAL FDA: approved

  2. desvenlafaxine succinate

    DESVENLAFAXINE SUCCINATE

    ORAL FDA: approved

  3. deucravacitinib

    SOTYKTU Bristol-Myers Squibb Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    L04AF07

  4. deuruxolitinib phosphate

    LEQSELVI

    ORAL FDA: approved

  5. deutetrabenazine

    AUSTEDO Teva Pharma GmbH

    ORAL FDA: approved · EMA: approved

    N07XX16

  6. deutivacaftor

    ALYFTREK Vertex Pharmaceuticals (Australia) Pty.

    ORAL FDA: approved

  7. deutivacaftor / tezacaftor / vanzacaftor

    ALYFTREK Vertex Pharmaceuticals (Australia) Pty.

    EMA: approved

    R07AX33

  8. dexamethasone

    DEXMETHSONE Lacuna Pharma Pty Ltd

    INTRAVITREAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    H02AB02

  9. dexamethasone acetate

    DEXAMETHASONE ACETATE Teva Pharma GmbH

    INJECTION FDA: approved

  10. dexamethasone phosphate

    DEXAMETHASONE TAW

    EMA: application withdrawn

    H02AB02

  11. dexamethasone sodium phosphate

    DEXAMETHASONE SODIUM PHOSPHATE Amneal Pharma Europe Ltd

    OPHTHALMIC, OTIC FDA: approved

  12. dexamfetamine

    ASPEN PHARMACARE AUSTRALIA PTY LTD Lacuna Pharma Pty Ltd

    TGA: approved

  13. dexborneol

    NMPA: clinical trials

  14. dexbrompheniramine maleate

    BROMPHERIL

    ORAL FDA: approved

  15. dexchlorpheniramine maleate

    DEXCHLORPHENIRAMINE MALEATE

    ORAL FDA: approved

  16. dexketoprofen-multiple

    NMPA: clinical trials

  17. dexketoprofen-single

    NMPA: clinical trials

  18. dexlansoprazole

    DEXLANSOPRAZOLE Takeda

    ORAL FDA: approved

  19. dexmedetomidine

    DEXDOR

    EMA: approved · NMPA: clinical trials

    N05CM18

  20. dexmedetomidine hydrochloride

    PRECEDEX PARTIAL CHANGE APPROVAL Regeneron Ireland Designated Activity Company (DAC)

    BUCCAL, SUBLINGUAL FDA: approved · PMDA: approved

  21. dexmedetomidine-esketamine

    NMPA: clinical trials

  22. dexmethylphenidate hydrochloride

    DEXMETHYLPHENIDATE HYDROCHLORIDE Teva Pharma GmbH

    ORAL FDA: approved

  23. dexrazoxane

    SAVENE

    EMA: approved

    V03AF02

  24. dexrazoxane hydrochloride

    DEXRAZOXANE HYDROCHLORIDE

    INJECTION FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources